Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.

IF 4.5 3区 医学 Q1 CLINICAL NEUROLOGY
Journal of Psychopharmacology Pub Date : 2024-08-01 Epub Date: 2024-06-18 DOI:10.1177/02698811241257839
Philip Todd Korthuis, Kim Hoffman, Adrianne R Wilson-Poe, Jason B Luoma, Alissa Bazinet, Kellie Pertl, David L Morgan, Ryan R Cook, Sarann Bielavitz, Renae Myers, Robert Cameron Wolf, Dennis McCarty, Christopher S Stauffer
{"title":"Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.","authors":"Philip Todd Korthuis, Kim Hoffman, Adrianne R Wilson-Poe, Jason B Luoma, Alissa Bazinet, Kellie Pertl, David L Morgan, Ryan R Cook, Sarann Bielavitz, Renae Myers, Robert Cameron Wolf, Dennis McCarty, Christopher S Stauffer","doi":"10.1177/02698811241257839","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Voter initiatives in Oregon and Colorado authorize legal frameworks for supervised psilocybin services, but no measures monitor safety or outcomes.</p><p><strong>Aims: </strong>To develop core measures of best practices.</p><p><strong>Methods: </strong>A three-phase e-Delphi process recruited 36 experts with 5 or more years' experience facilitating psilocybin experiences in various contexts (e.g., ceremonial settings, indigenous practices, clinical trials), or other pertinent psilocybin expertise. Phase I, an on-line survey with qualitative, open-ended text responses, generated potential measures to assess processes, outcomes, and structure reflecting high quality psilocybin services. In Phase II, experts used seven-point Likert scales to rate the importance and feasibility of the Phase I measures. Measures were priority ranked. Qualitative interviews and analysis in Phase III refined top-rated measures.</p><p><strong>Results: </strong>Experts (<i>n</i> = 36; 53% female; 71% white; 56% heterosexual) reported currently providing psilocybin services (64%) for a mean of 15.2 [SD 13.1] years, experience with indigenous psychedelic practices (67%), and/or conducting clinical trials (36%). Thematic analysis of Phase I responses yielded 55 candidate process measures (e.g., preparatory hours with client, total dose of psilocybin administered, documentation of touch/sexual boundaries), outcome measures (e.g., adverse events, well-being, anxiety/depression symptoms), and structure measures (e.g., facilitator training in trauma informed care, referral capacity for medical/psychiatric issues). In Phase II and III, experts prioritized a core set of 11 process, 11 outcome, and 17 structure measures that balanced importance and feasibility.</p><p><strong>Conclusion: </strong>Service providers and policy makers should consider standardizing core measures developed in this study to monitor the safety, quality, and outcomes of community-based psilocybin services.</p>","PeriodicalId":16892,"journal":{"name":"Journal of Psychopharmacology","volume":" ","pages":"761-768"},"PeriodicalIF":4.5000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02698811241257839","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Voter initiatives in Oregon and Colorado authorize legal frameworks for supervised psilocybin services, but no measures monitor safety or outcomes.

Aims: To develop core measures of best practices.

Methods: A three-phase e-Delphi process recruited 36 experts with 5 or more years' experience facilitating psilocybin experiences in various contexts (e.g., ceremonial settings, indigenous practices, clinical trials), or other pertinent psilocybin expertise. Phase I, an on-line survey with qualitative, open-ended text responses, generated potential measures to assess processes, outcomes, and structure reflecting high quality psilocybin services. In Phase II, experts used seven-point Likert scales to rate the importance and feasibility of the Phase I measures. Measures were priority ranked. Qualitative interviews and analysis in Phase III refined top-rated measures.

Results: Experts (n = 36; 53% female; 71% white; 56% heterosexual) reported currently providing psilocybin services (64%) for a mean of 15.2 [SD 13.1] years, experience with indigenous psychedelic practices (67%), and/or conducting clinical trials (36%). Thematic analysis of Phase I responses yielded 55 candidate process measures (e.g., preparatory hours with client, total dose of psilocybin administered, documentation of touch/sexual boundaries), outcome measures (e.g., adverse events, well-being, anxiety/depression symptoms), and structure measures (e.g., facilitator training in trauma informed care, referral capacity for medical/psychiatric issues). In Phase II and III, experts prioritized a core set of 11 process, 11 outcome, and 17 structure measures that balanced importance and feasibility.

Conclusion: Service providers and policy makers should consider standardizing core measures developed in this study to monitor the safety, quality, and outcomes of community-based psilocybin services.

开发开放式迷幻药评估网络(Open Psychedelic Evaluation Nexus)共识措施,用于评估受监督的迷幻药服务:电子德尔菲研究。
背景:俄勒冈州和科罗拉多州的选民倡议批准了受监督的迷幻剂服务的法律框架,但没有对其安全性或结果进行监测:俄勒冈州和科罗拉多州的选民倡议批准了监督下的迷幻剂服务的法律框架,但没有监测安全性或结果的措施:方法:通过三阶段的 e-Delphi 流程招募了 36 名专家,他们在不同的环境(如仪式环境、土著实践、临床试验)中拥有 5 年或 5 年以上的促进迷幻剂体验的经验,或拥有其他相关的迷幻剂专业知识。第一阶段是在线调查,采用定性、开放式文本回答,产生了潜在的评估措施,以评估反映高质量迷幻剂服务的过程、结果和结构。在第二阶段,专家们使用七点李克特量表对第一阶段措施的重要性和可行性进行评分。对各项措施进行了优先排序。第三阶段的定性访谈和分析完善了评级最高的措施:专家(n = 36;53% 为女性;71% 为白人;56% 为异性恋者)称目前提供迷幻剂服务(64%),平均年限为 15.2 [SD 13.1]年,具有本土迷幻剂实践经验(67%),和/或正在进行临床试验(36%)。对第一阶段的回复进行主题分析后,得出了 55 项候选过程测量指标(例如,与客户的准备时间、施用的迷幻剂总剂量、触摸/性界限记录)、结果测量指标(例如,不良事件、幸福感、焦虑/抑郁症状)和结构测量指标(例如,促进者在创伤知情护理方面的培训、医疗/精神问题的转诊能力)。在第二阶段和第三阶段,专家们在重要性和可行性之间进行了权衡,优先确定了一套由 11 个过程、11 个结果和 17 个结构措施组成的核心措施:结论:服务提供者和政策制定者应考虑将本研究中制定的核心衡量标准标准化,以监控基于社区的迷幻剂服务的安全性、质量和结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Psychopharmacology
Journal of Psychopharmacology 医学-精神病学
CiteScore
8.60
自引率
4.90%
发文量
126
审稿时长
3-8 weeks
期刊介绍: The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信